Chemical synthesis
We have deeply cultivated the field of proprietary chemical synthesis for nucleic acid drug raw materials, establishing a full-scale synthesis system ranging from milligram to kilogram levels. Leveraging our specialized production base in Tianjin, we have seamlessly integrated the entire production chain—from starting materials to finished products—while adhering to the QbD (Quality by Design) philosophy throughout the entire process, thereby achieving dual optimization of quality and cost. Relying on our profound technological expertise, we have obtained numerous national invention patents and can stably supply a wide range of products, including GalNAc delivery systems, oligonucleotides, mRNA raw materials, and functional linkers, efficiently supporting the entire lifecycle needs—from research and development to commercial manufacturing.
Quality control
We have established a comprehensive, multi-dimensional quality control system equipped with cutting-edge international testing instruments, including ultra-high-performance liquid chromatography (UPLC), high-resolution mass spectrometry (HRMS), and nuclear magnetic resonance spectroscopy (NMR). Adhering to stringent standards such as ISO and GMP, we conduct a full range of tests—including purity analysis, structural confirmation, stability studies, and impurity profiling—on raw materials, intermediates, and finished products. This ensures that the quality of each batch is consistent and fully controllable, and provides customers with complete, traceable quality test reports.
Customized service
We offer a one-stop, customized service—from R&D to commercialization—tailored to meet our clients’ specific needs in the field of small nucleic acid drug raw materials. These needs include specialized structural modifications, tailored purity specifications, custom packaging, and flexible delivery schedules. We assemble dedicated technical teams to analyze client requirements and design customized solutions. Throughout the entire process, we adopt a project-based management approach, ensuring seamless integration between R&D and production, efficiently responding to the rapid iterative demands of innovative drug development, and helping our clients accelerate their project timelines.
Service hotline:
Company email:
Share
